YUERONG BAYER: Open Payments
NPI 1184134561 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 10 payments from 9 companies in 2025. Trend: 2023 $1,612 · 2024 $1,389 · 2025 $210
Food & beverage: $155Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $55 |
| ABBVIE INC. | 2 | $39 |
| Corcept Therapeutics | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
Products named: TREMFYA, Korlym, OTEZLA, QULIPTA, LINZESS, JARDIANCE, FARXIGA, MOUNJARO.
Industry payments across OH — which companies pay providers there.
